Many newer primary care professionals have limited experience of psychiatry, yet need to manage patients on multiple medications including antidepressants. This article outlines common prescribing dilemmas and solutions for novice primary care prescribers managing patients who require antidepressant therapy.
{"title":"A guide to prescribing antidepressants in primary care","authors":"A. Woodall, L. Walker","doi":"10.1002/psb.2006","DOIUrl":"https://doi.org/10.1002/psb.2006","url":null,"abstract":"Many newer primary care professionals have limited experience of psychiatry, yet need to manage patients on multiple medications including antidepressants. This article outlines common prescribing dilemmas and solutions for novice primary care prescribers managing patients who require antidepressant therapy.","PeriodicalId":88184,"journal":{"name":"The Prescriber","volume":"25 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83303773","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Crizanlizumab (Adakveo) is a new monoclonal antibody therapy for the prevention of recurrent vaso‐occlusive crises in patients with sickle cell disease. This article discusses its mode of action, efficacy and place in therapy.
{"title":"Crizanlizumab to prevent crises in sickle cell disease","authors":"S. Chaplin","doi":"10.1002/psb.2012","DOIUrl":"https://doi.org/10.1002/psb.2012","url":null,"abstract":"Crizanlizumab (Adakveo) is a new monoclonal antibody therapy for the prevention of recurrent vaso‐occlusive crises in patients with sickle cell disease. This article discusses its mode of action, efficacy and place in therapy.","PeriodicalId":88184,"journal":{"name":"The Prescriber","volume":"41 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86971626","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
This year's Clinical Pharmacy Congress (CPC), held in London in May, covered a diverse range of topics including the role of pharmacy in greener healthcare, managing lipids and treating epilepsy. Joy Ogden reports on some of the highlights of the congress.
{"title":"Highlights of the 2022 Clinical Pharmacy Congress","authors":"J. Ogden","doi":"10.1002/psb.2009","DOIUrl":"https://doi.org/10.1002/psb.2009","url":null,"abstract":"This year's Clinical Pharmacy Congress (CPC), held in London in May, covered a diverse range of topics including the role of pharmacy in greener healthcare, managing lipids and treating epilepsy. Joy Ogden reports on some of the highlights of the congress.","PeriodicalId":88184,"journal":{"name":"The Prescriber","volume":"40 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85837696","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Fungal infection is the fifth largest cause of death worldwide, yet fungi attract far less interest from researchers than viruses, bacteria or even parasites. However, the concerning rise in resistant fungi is at last focusing more attention on the development of innovative antifungal agents.
{"title":"Why have we neglected fungal infections?","authors":"M. Greener","doi":"10.1002/psb.2008","DOIUrl":"https://doi.org/10.1002/psb.2008","url":null,"abstract":"Fungal infection is the fifth largest cause of death worldwide, yet fungi attract far less interest from researchers than viruses, bacteria or even parasites. However, the concerning rise in resistant fungi is at last focusing more attention on the development of innovative antifungal agents.","PeriodicalId":88184,"journal":{"name":"The Prescriber","volume":"5 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89015154","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Getting under the skin of fungal infections","authors":"","doi":"10.1002/psb.2005","DOIUrl":"https://doi.org/10.1002/psb.2005","url":null,"abstract":"","PeriodicalId":88184,"journal":{"name":"The Prescriber","volume":"39 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91147304","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Abrocitinib (Cibinqo) is a new janus kinase inhibitor for the treatment of moderate to severe atopic dermatitis in adults and adolescents. This article reviews its properties and place in therapy.
{"title":"Abrocitinib for the treatment of atopic dermatitis","authors":"S. Chaplin","doi":"10.1002/psb.2011","DOIUrl":"https://doi.org/10.1002/psb.2011","url":null,"abstract":"Abrocitinib (Cibinqo) is a new janus kinase inhibitor for the treatment of moderate to severe atopic dermatitis in adults and adolescents. This article reviews its properties and place in therapy.","PeriodicalId":88184,"journal":{"name":"The Prescriber","volume":"54 6 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87349557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NICE has recently updated its guideline on diagnosing and managing epilepsies in children, young people and adults (NG217). This article provides a brief summary of the new guidance, which provides detailed recommendations on assessment, referral and management of different epilepsy and seizure types.
{"title":"Updated guideline on diagnosing and managing epilepsies","authors":"S. Chaplin","doi":"10.1002/psb.2010","DOIUrl":"https://doi.org/10.1002/psb.2010","url":null,"abstract":"NICE has recently updated its guideline on diagnosing and managing epilepsies in children, young people and adults (NG217). This article provides a brief summary of the new guidance, which provides detailed recommendations on assessment, referral and management of different epilepsy and seizure types.","PeriodicalId":88184,"journal":{"name":"The Prescriber","volume":"29 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84390515","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
… but not in a delightful way. Some patients prefer to take their medicines as soluble tablets, but these products sometimes contain clinically significant amounts of sodium, which if taken regularly at high doses can add up to the equivalent of an alarming amount of salt, cautions Angus Thompson.
{"title":"A spoonful of salt helps the medicine go down…","authors":"A. Thompson","doi":"10.1002/psb.2004","DOIUrl":"https://doi.org/10.1002/psb.2004","url":null,"abstract":"… but not in a delightful way. Some patients prefer to take their medicines as soluble tablets, but these products sometimes contain clinically significant amounts of sodium, which if taken regularly at high doses can add up to the equivalent of an alarming amount of salt, cautions Angus Thompson.","PeriodicalId":88184,"journal":{"name":"The Prescriber","volume":"28 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78156018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Celebrating research in primary care","authors":"","doi":"10.1002/psb.1997","DOIUrl":"https://doi.org/10.1002/psb.1997","url":null,"abstract":"","PeriodicalId":88184,"journal":{"name":"The Prescriber","volume":"2 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91097218","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：